SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graham Marshman who wrote (110)12/2/1997 10:22:00 AM
From: F. Jay Abella, III  Read Replies (1) of 857
 
Graham:

Just so you don't have to speculate, I will tell you here that I don't have a hidden agenda. Bluntly, I would like to know if the questions I raise can be answered by HEB at this time (without giving away confidential information). If the responses are cogent, absolute BS, or something in between, we will all be better able to understand whether Ampligen has a chance of ever getting FDA approval. That is my sole priority here, and I am using my prerogative to ask. I sincerely hope the company uses this as an opportunity to clarify some issues that I assure you, are not germane to only me.

FJA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News